Convexity Labs

FDUS

Convexity Analyst · FDUS
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: FDUS (Fidus Investment Corporation)

Date: 2026-06-13 Current Price: $18.35

1. Structural Readiness

  • State: Forming.
  • Conservative Entry: Not yet defined (requires confirmed breakout).
  • Aggressive/Pre-Breakout Entry: Not actionable on setup alone; requires confirmation.
  • Breakout Level: Not yet defined.
  • Current Price: $18.35.
  • Extension: Not applicable (price is within the consolidation range, not extended above a breakout level).
  • ATR Context: Current ATR is 2.2% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently pricing in stability or waiting for a catalyst.
  • Classification: The setup is FORMING. This is a partial signal. While the structure is in place and price is holding above the implied support, the lack of a breakout means the setup is not yet confirmed. A forming coil is not invalidated; it is simply incomplete.

2. Thesis Layer

This is a TACTICAL, setup-led name. As of 2026-06-13, there is no named secular thesis driving this specific setup. The investment case must be judged strictly on the quality of the technical structure (setup readiness) and the underlying business fundamentals (BDC performance), rather than a macroeconomic tailwind or sector-wide rotation. No macro thesis should be invented to force a conviction score.

3. Business Overview

Fidus Investment Corporation operates as a Business Development Company (BDC) providing customized debt and equity financing solutions to lower middle-market U.S. companies.

  • Target Market: Companies with revenues between $10.0 million and $150.0 million (E15).
  • Investment Strategy: The firm partners with business owners and financial sponsors for ownership transactions, recapitalizations, strategic acquisitions, and growth initiatives. Notably, the company explicitly refrains from investing in distressed companies or those undergoing turnarounds (E26).
  • Portfolio Composition: As of December 31, 2025, the portfolio consisted of 103 companies with an aggregate fair value of $1.3 billion (E16, E22). The portfolio is well-diversified across industries including manufacturing, distribution, services, healthcare, and information technology (E4, E19).
  • Recent Performance (Q1 2026):
  • Adjusted Net Investment Income (NII): Grew 14.8% to $23.7 million, driven by a 13.1% increase in interest income and higher fee income (E1).
  • Originations: First-quarter originations totaled $118.7 million, primarily consisting of first-lien debt investments supporting M&A and debt recapitalizations (E2).
  • Asset Quality: First-lien investments comprised 87% of the debt portfolio, reflecting a continued migration toward senior secured securities (E6).
  • Yield: The weighted average yield on debt investments was 12.6% as of December 31, 2025 (E17).
  • NAV: Net asset value per common share was $19.55 as of the end of Q1 2026 (E14).
  • Dividends: Dividends declared per share were $0.52 for the period, compared to $0.54 in the prior period (E13).
  • Management Expectations: Management expects an "okay to decent" originations quarter with lighter-than-average repayments (E3).

4. Archetype and Conviction

  • Archetype: Quality Compounder.
  • Rationale: The company demonstrates consistent growth in NII (14.8% YoY), a disciplined focus on first-lien senior debt (87% of portfolio), and a strategy that avoids distressed assets. The portfolio has grown from 91 to 103 companies with fair value increasing from $1.1 billion to $1.3 billion year-over-year, indicating organic and inorganic growth without compromising asset quality (E22).
  • Valuation Context:
  • Market vs. NAV: The current market price of $18.35 trades at a discount to the reported Net Asset Value (NAV) of $19.55 (E14).
  • Earnings Power: Forward consensus EPS for FY1 is $2.122 and FY2 is $1.956 (E27).
  • Total Return: For the year ended December 31, 2025, total return based on NAV was 12.0%, while total return based on market value was 0.6% (E20). This divergence highlights the current market discount relative to the underlying book value.
  • Conviction Stack:
  • Thesis Strength: Low (Tactical/Setup-led, no macro thesis).
  • Evidence Quality: High (Strong earnings growth, clear portfolio metrics, disciplined strategy).
  • Structural Quality: Moderate (Forming coil, sub-threshold ATR).
  • Setup Readiness: Partial (Structure in place, awaiting breakout).
  • Rerating Potential: Moderate (Potential for market price to converge toward NAV if the breakout confirms).

5. Invalidations, Strengths, and Gaps

  • What Would Strengthen: A confirmed breakout above the consolidation resistance with volume, or management raising guidance on originations beyond the "okay to decent" expectation.
  • Gaps in Evidence:
  • Sector Classification: The specific sector and industry labels for the technical setup are missing from the provided data.
  • Capex/Guidance Details: While originations are discussed, specific capital expenditure plans or detailed balance sheet leverage ratios for the current quarter are not explicitly detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Adjusted NII grew 14.8% to $23.7 million in Q1 2026; First-lien investments comprise 87% of the debt portfolio; Market price ($18.35) trades at a discount to NAV ($19.55); Portfolio fair value grew from $1.1B to $1.3B YoY. Key risks: Technical setup is forming but not yet confirmed (no breakout); Current ATR is sub-threshold (2.2%), indicating low volatility and potential lack of immediate momentum; Dividend per share decreased slightly from $0.54 to $0.52; Market return lagged NAV return significantly in the prior year. Sizing hint: Position size should reflect the partial setup readiness; treat as a core holding with a wait-and-see approach until the breakout confirms. Expected path: Management expects okay to decent originations with lighter repayments; if the technical breakout occurs, the market price may begin to converge toward the $19.55 NAV. Expected horizon: 3 to 6 months for the technical setup to resolve or for the fundamental thesis to drive a re-rating.

Loading chart...
Exhibit 1: FDUS daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for FDUS.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for FDUS.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: